Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Immunologicals & Biologicals Corporation has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 11th August 2022, to approve the financial results of the Company for the quarter ended 30th June 2022.
The above information is a part of company’s filings submitted to BSE.